Literature DB >> 34496290

Tumor-induced disruption of the blood-brain barrier promotes host death.

Jung Kim1, Hsiu-Chun Chuang1, Natalie K Wolf1, Christopher J Nicolai1, David H Raulet1, Kaoru Saijo2, David Bilder3.   

Abstract

Cancer patients often die from symptoms that manifest at a distance from any tumor. Mechanisms underlying these systemic physiological perturbations, called paraneoplastic syndromes, may benefit from investigation in non-mammalian systems. Using a non-metastatic Drosophila adult model, we find that malignant-tumor-produced cytokines drive widespread host activation of JAK-STAT signaling and cause premature lethality. STAT activity is particularly high in cells of the blood-brain barrier (BBB), where it induces aberrant BBB permeability. Remarkably, inhibiting STAT in the BBB not only rescues barrier function but also extends the lifespan of tumor-bearing hosts. We identify BBB damage in other pathological conditions that cause elevated inflammatory signaling, including obesity and infection, where BBB permeability also regulates host survival. IL-6-dependent BBB dysfunction is further seen in a mouse tumor model, and it again promotes host morbidity. Therefore, BBB alterations constitute a conserved lethal tumor-host interaction that also underlies other physiological morbidities.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drosophila; IL-6; blood-brain barrier; cancer; cancer model; cytokine; inflammation; mouse; paraneoplasia; tumor

Mesh:

Substances:

Year:  2021        PMID: 34496290      PMCID: PMC8511098          DOI: 10.1016/j.devcel.2021.08.010

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   13.417


  48 in total

1.  Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier.

Authors:  Yasunobu Arima; Masaya Harada; Daisuke Kamimura; Jin-Haeng Park; Fuminori Kawano; Fiona E Yull; Tadafumi Kawamoto; Yoichiro Iwakura; Ulrich A K Betz; Gabriel Márquez; Timothy S Blackwell; Yoshinobu Ohira; Toshio Hirano; Masaaki Murakami
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

2.  Mutations in erupted, the Drosophila ortholog of mammalian tumor susceptibility gene 101, elicit non-cell-autonomous overgrowth.

Authors:  Kenneth H Moberg; Suzanne Schelble; Sharon K Burdick; Iswar K Hariharan
Journal:  Dev Cell       Date:  2005-11       Impact factor: 12.270

Review 3.  Targeting the IL-6/JAK/STAT3 signalling axis in cancer.

Authors:  Daniel E Johnson; Rachel A O'Keefe; Jennifer R Grandis
Journal:  Nat Rev Clin Oncol       Date:  2018-02-06       Impact factor: 66.675

4.  Neoplasms in mutant and cultured wild-tupe tissues of Drosophila.

Authors:  E Gateff; H A Schneiderman
Journal:  Natl Cancer Inst Monogr       Date:  1969-07

5.  Malignant Drosophila tumors interrupt insulin signaling to induce cachexia-like wasting.

Authors:  Alejandra Figueroa-Clarevega; David Bilder
Journal:  Dev Cell       Date:  2015-04-06       Impact factor: 12.270

6.  Tumor-Derived Ligands Trigger Tumor Growth and Host Wasting via Differential MEK Activation.

Authors:  Wei Song; Serkan Kir; Shangyu Hong; Yanhui Hu; Xiaohui Wang; Richard Binari; Hong-Wen Tang; Verena Chung; Alexander S Banks; Bruce Spiegelman; Norbert Perrimon
Journal:  Dev Cell       Date:  2019-01-10       Impact factor: 12.270

Review 7.  Cytokines and their relationship to the symptoms and outcome of cancer.

Authors:  Bostjan Seruga; Haibo Zhang; Lori J Bernstein; Ian F Tannock
Journal:  Nat Rev Cancer       Date:  2008-10-10       Impact factor: 60.716

8.  Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response.

Authors:  Assaf Marcus; Amy J Mao; Monisha Lensink-Vasan; LeeAnn Wang; Russell E Vance; David H Raulet
Journal:  Immunity       Date:  2018-10-16       Impact factor: 31.745

9.  Tumour-derived Dilp8/INSL3 induces cancer anorexia by regulating feeding neuropeptides via Lgr3/8 in the brain.

Authors:  Eunbyul Yeom; Hyemi Shin; Wonbeak Yoo; Eunsung Jun; Seokho Kim; Seung Hyun Hong; Dae-Woo Kwon; Tae Hoon Ryu; Jae Myoung Suh; Song Cheol Kim; Kyu-Sun Lee; Kweon Yu
Journal:  Nat Cell Biol       Date:  2021-02-08       Impact factor: 28.824

10.  Macrophage-derived upd3 cytokine causes impaired glucose homeostasis and reduced lifespan in Drosophila fed a lipid-rich diet.

Authors:  Katie J Woodcock; Katrin Kierdorf; Clara A Pouchelon; Valérie Vivancos; Marc S Dionne; Frédéric Geissmann
Journal:  Immunity       Date:  2015-01-20       Impact factor: 31.745

View more
  8 in total

1.  Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study.

Authors:  Jeanne S Mandelblatt; Tim A Ahles; James C Root; Xingtao Zhou; Jaeil Ahn; Brent J Small; Wanting Zhai; Traci Bethea; Judith E Carroll; Harvey Jay Cohen; Asma Dilawari; Martine Extermann; Deena Graham; Claudine Isaacs; Paul B Jacobsen; Heather Jim; Brenna C McDonald; Zev M Nakamura; Sunita K Patel; Kelly Rentscher; Andrew J Saykin; Kathleen Van Dyk
Journal:  Breast Cancer Res Treat       Date:  2022-05-19       Impact factor: 4.624

Review 2.  Sleep Disruption and Cancer: Chicken or the Egg?

Authors:  Adrian Berisha; Kyle Shutkind; Jeremy C Borniger
Journal:  Front Neurosci       Date:  2022-05-19       Impact factor: 5.152

Review 3.  Cancer cachexia: lessons from Drosophila.

Authors:  Ying Liu; Pedro Saavedra; Norbert Perrimon
Journal:  Dis Model Mech       Date:  2022-03-23       Impact factor: 5.758

4.  Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis.

Authors:  Ruo-Yue Fan; Jia-Qi Wu; Yu-Yang Liu; Xiang-Yu Liu; Si-Tong Qian; Chong-Yong Li; Ping Wei; Zhe Song; Ming-Fang He
Journal:  J Exp Clin Cancer Res       Date:  2021-11-20

5.  Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts.

Authors:  Elin Almstedt; Emil Rosén; Marleen Gloger; Rebecka Stockgard; Neda Hekmati; Katarzyna Koltowska; Cecilia Krona; Sven Nelander
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

6.  Timing of Tocilizumab Administration Under the Guidance of IL-6 in CAR-T Therapy for R/R Acute Lymphoblastic Leukemia.

Authors:  Yinqiang Zhang; Fen Zhou; Zhuolin Wu; Yingnan Li; Chenggong Li; Mengyi Du; Wenjing Luo; Haiming Kou; Cong Lu; Heng Mei
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

7.  A Wholistic View of How Bumetanide Attenuates Autism Spectrum Disorders.

Authors:  Eric Delpire; Yehezkel Ben-Ari
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

Review 8.  Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis.

Authors:  Nicolás Lundahl Ciano-Petersen; Sergio Muñiz-Castrillo; Cristina Birzu; Alberto Vogrig; Antonio Farina; Macarena Villagrán-García; Bastien Joubert; Dimitri Psimaras; Jérôme Honnorat
Journal:  Brain Commun       Date:  2022-08-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.